Patent Assignment
Reel/Frame 014525/0497
Assignment of Assignor's Interest
Recorded: 2003-09-16
Pages: 4
Assignee
PANACOS PHARMACEUTICALS, INC.
209 PERRY PARKWAY, GAITHERSBURG, MARYLAND, 20877
Covered Property
(1)
Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteins
Application:
09/809,060 →
Publication:
US 2002/0010317
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Sep 29, 2003
From: PANACOS PHARMACEUTICALS, INC.
To: A.M. PAPPAS LIFE SCIENCE VENTURES I, L.P., AS COLLATERAL AGENT; AMPERSAND 1999 LIMITED PARTNERSHIP; AMPERSAND 1999 COMPANION FUND LIMITED PARTNERSHIP; MARYLAND DEPARTMENT OF BUSINESS AND ECONOMIC DEVELOPMENT
Reel/Frame 014539/0788 →
Security Agreement
Apr 23, 2004
From: PANACOS PHARMACEUTICALS, INC.
To: GATX VENTURES, INC.
Reel/Frame 014532/0193 →
Payee Financing Notice and Conversion Agreement (Terminates Ip Security Agmt)
Aug 6, 2004
From: A.M. PAPPAS LIFE SCIENCE VENTURES I, L.P. AS COLLATERAL AGENT; AMPERSAND 1999 LIMITED PARTNERSHIP; AMPERSAND 1999 COMPANION FUND LIMITED PARTNERSHIP; MARYLAND DEPARTMENT OF BUSINESS AND ECONOMIC DEVELOPMENT
To: PANACOS PHARMACEUTICALS, INC.
Reel/Frame 015642/0819 →
Termination of Security Interest
Sep 22, 2004
From: PANACOS PHARMACEUTICALS, INC.
To: GATX VENTURES, INC.
Reel/Frame 015156/0176 →
Change of Name
Nov 18, 2005
From: V.I. TECHNOLOGIES, INC.
To: PANACOS PHARMACEUTICALS, INC.
Reel/Frame 016793/0400 →
Merger
Nov 18, 2005
From: PANACOS PHARMACEUTICALS, INC.
To: V.I. TECHNOLOGIES, INC.
Reel/Frame 016793/0407 →